Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Senate Targets Hoarding of Drug Patents to Deter Competition
Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem
Examining the Truvada #BreakThePatent Debate: Gilead Responds
Why Abbvie May Have A Tough Time Defending Humira’s Price Before Congress
It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment
World’s best-selling drug costs five times more in U.S. than Europe
This billionaire couple is taking on Big Pharma to lower your prescription drug prices
Bringing the medicine access fight to the US
Beyond “Capacity Building”: Crafting Partnerships Based on Equality
How Big Pharma secures drug monopolies